Artificial Blood Vessels Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The market is segmented by Application (Aortic Disease, Peripheral artery disease, Hemodialysis), Polymer, and Geography

Market Snapshot

Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.3 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The people are facing problems of blocked blood vessels that can cause some extreme life-threatening conditions. Hence, it is essential to replace a damaged blood vessel either by artificial vascular prostheses or through another arteries or veins from the body. The research institutes have thus developed artificial blood vessels made from special polymers, that has exceptional mechanical properties. 

Surgeons initially transplanted veins or arteries from donors to replace the damaged or diseased arteries from human body. Transplanting vessels from the patient's own body has various problems such as, development of arteriosclerosis and several post-surgery complications. Hence, to avoid such difficulties, artificial blood vessels were created by researchers, thus augmenting market growth.

However, presence of a stringent regulatory framework for the approval of artificial vessels will limit market growth. Moreover, high cost associated with transplants and surgeries will further impede market growth.

Scope of the Report

As per the scope of the report, artificial blood vessels are tubes made from synthetic (chemically produced) materials to restore blood circulation.These synthetic blood vessels are manufactured by using biosynthetic materials such as polyethylene terephthalate and Polydioxanone owing to high water and chemical resistance, high conductivity and high permeability to oxygen. 

In the report, a detailed analysis of the artificial blood vessels market is provided. The market is evaluated by collating revenues generated across segments, categorized by Application, Polymer, and Geography.

By Application
Aortic Disease
Peripheral Artery Disease
Hemodialysis
By Polymer
Polydioxanone
Elastomer
Polyethylene Terephthalate
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Application in Aortic Disease is Expected to cover a Large Share of the Market

The aorta is the largest artery in the body. Oxygen-rich blood enters the aorta and the heart pumps the blood out of the aorta where it travels to the rest of the body via the smaller arteries that branch out from it. A variety of diseases and conditions can cause damage to the aorta and put patients at great, life-threatening risk. Those conditions include atherosclerosis, hypertension, genetic conditions, connective tissue disorders, and injury.

As per a report 2015 report by D. P. J. Howard et al., published in Wiley Online Library, the incidence of acute abdominal aortic aneurysm (AAA) events per 100 000 population per year was 55 in men aged between 65 and 74 years, but increased to 112 at age between 75 and 84 years and to 298 at age 85 years or above. Therefore as the geriatric population is increasing as per 2017 report on "World Aging Population" by the United Nations. Hence, the prevalence of aortic diseases is expected to increase in the future.

When aneurysm ruptures, surgery is needed. Surgery thus involves removing the section of aorta where the aneurysm is and replacing it with an artificial blood vessel. Therefore with the increasing incidence, artificial blood vessels application is expected to increase and this in turn will help the market growth.

Graph - new

North America is Expected to Dominate the Artificial Blood Vessels Market

North America holds the major share of the market due to well-developed healthcare infrastructure, and technology advancements in this region.

Besides, growing prevalence of aortic diseases in the U.S. is also likely to boost market growth. As per Center for Diseases Control and Prevention 2019 report, aortic aneurysms were the cause of 9,928 deaths in 2017 in the United States. The number of smokers, who are more prone to aortic diseases are also incresing in the US.Hence, growing burden of such diseases will augment the artificial blood vessels market. 
However, the United States also have a developed and well-structured health care system. These systems also encourage research and development. These policies encourage global players to enter the US and Canada. As a result, these countries enjoy the presence of many global market players. As high and increasing demand is met by the presence of global players in the region, the market is further expected to increase.

Countries

Competitive Landscape

Majority of the artificial blood vessels are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Aortic Diseases

      2. 4.2.2 Growing Adoption of Minimally Invasive Surgeries

      3. 4.2.3 Technoloigical Advancements in Development of Artificial Blood Vessels

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost Associated with Transplants and Surgeries

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Application

      1. 5.1.1 Aortic Disease

      2. 5.1.2 Peripheral Artery Disease

      3. 5.1.3 Hemodialysis

    2. 5.2 By Polymer

      1. 5.2.1 Polydioxanone

      2. 5.2.2 Elastomer

      3. 5.2.3 Polyethylene Terephthalate

      4. 5.2.4 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 B. Braun Melsungen

      2. 6.1.2 Becton, Dickinson and Company

      3. 6.1.3 Cook Medical Incorporated

      4. 6.1.4 Humacyte Inc.

      5. 6.1.5 Jotec GmbH

      6. 6.1.6 LeMaitre Vascular Inc

      7. 6.1.7 Medtronic

      8. 6.1.8 Techshot Inc

      9. 6.1.9 Terumo Medical Corporation

      10. 6.1.10 W. L. Gore and Associates

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Artificial Blood Vessels Market market is studied from 2018 - 2026.

The Artificial Blood Vessels Market is growing at a CAGR of 5.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

B. Braun Melsungen, Terumo Medical Corporation, Medtronic, Cook Medical Incorporated, Becton, Dickinson and Company are the major companies operating in Artificial Blood Vessels Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!